Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Yap1 activation enables bypass of oncogenic kras addiction in pancreatic cancer.

Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q, Zhong Y, Wu CJ, Sadanandam A, Hu B, Chang Q, Chu GC, Al-Khalil R, Jiang S, Xia H, Fletcher-Sananikone E, Lim C, Horwitz GI, Viale A, Pettazzoni P, Sanchez N, Wang H, Protopopov A, Zhang J, Heffernan T, Johnson RL, Chin L, Wang YA, Draetta G, DePinho RA.

Cell. 2014 Jul 3;158(1):185-97. doi: 10.1016/j.cell.2014.06.003. Epub 2014 Jun 19.

PMID:
24954535
[PubMed - in process]
2.

Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications.

Sadanandam A, Wang X, de Sousa E Melo F, Gray JW, Vermeulen L, Hanahan D, Medema JP.

Cell Cycle. 2014 Feb 1;13(3):353-7. doi: 10.4161/cc.27769. Epub 2014 Jan 9.

PMID:
24406433
[PubMed - in process]
3.

Identification and characterization of poorly differentiated invasive carcinomas in a mouse model of pancreatic neuroendocrine tumorigenesis.

Hunter KE, Quick ML, Sadanandam A, Hanahan D, Joyce JA.

PLoS One. 2013 May 14;8(5):e64472. doi: 10.1371/journal.pone.0064472. Print 2013.

PMID:
23691228
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, Ostos LC, Lannon WA, Grotzinger C, Del Rio M, Lhermitte B, Olshen AB, Wiedenmann B, Cantley LC, Gray JW, Hanahan D.

Nat Med. 2013 May;19(5):619-25. doi: 10.1038/nm.3175. Epub 2013 Apr 14.

PMID:
23584089
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?

Sadanandam A, Lal A, Benz SC, Eppenberger-Castori S, Scott G, Gray JW, Spellman P, Waldman F, Benz CC.

Breast Cancer Res Treat. 2012 Dec;136(3):693-703. doi: 10.1007/s10549-012-2290-3. Epub 2012 Oct 27.

PMID:
23104223
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation.

Sadanandam A, Sidhu SS, Wullschleger S, Singh S, Varney ML, Yang CS, Ashour AE, Batra SK, Singh RK.

Br J Cancer. 2012 Jul 24;107(3):501-7. doi: 10.1038/bjc.2012.298. Epub 2012 Jul 10.

PMID:
22782341
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

In silico evaluation of TERT inhibition by anticancer drugs.

Mahendar P, Sirisha K, Kulandaivelu U, Shankar PL, Radhika T, Sadanandam A.

J Mol Model. 2012 Oct;18(10):4739-44. doi: 10.1007/s00894-012-1455-7. Epub 2012 Jun 6.

PMID:
22669532
[PubMed - indexed for MEDLINE]
8.

Subtype and pathway specific responses to anticancer compounds in breast cancer.

Heiser LM, Sadanandam A, Kuo WL, Benz SC, Goldstein TC, Ng S, Gibb WJ, Wang NJ, Ziyad S, Tong F, Bayani N, Hu Z, Billig JI, Dueregger A, Lewis S, Jakkula L, Korkola JE, Durinck S, Pepin F, Guan Y, Purdom E, Neuvial P, Bengtsson H, Wood KW, Smith PG, Vassilev LT, Hennessy BT, Greshock J, Bachman KE, Hardwicke MA, Park JW, Marton LJ, Wolf DM, Collisson EA, Neve RM, Mills GB, Speed TP, Feiler HS, Wooster RF, Haussler D, Stuart JM, Gray JW, Spellman PT.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9. doi: 10.1073/pnas.1018854108. Epub 2011 Oct 14.

PMID:
22003129
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.

Sadanandam A, Futakuchi M, Lyssiotis CA, Gibb WJ, Singh RK.

BMC Cancer. 2011 Jul 20;11:304. doi: 10.1186/1471-2407-11-304.

PMID:
21774828
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors.

Sirisha K, Shekhar MC, Umasankar K, Mahendar P, Sadanandam A, Achaiah G, Reddy VM.

Bioorg Med Chem. 2011 May 15;19(10):3249-54. doi: 10.1016/j.bmc.2011.03.051. Epub 2011 Mar 26.

PMID:
21530277
[PubMed - indexed for MEDLINE]
11.

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, Cooc J, Weinkle J, Kim GE, Jakkula L, Feiler HS, Ko AH, Olshen AB, Danenberg KL, Tempero MA, Spellman PT, Hanahan D, Gray JW.

Nat Med. 2011 Apr;17(4):500-3. doi: 10.1038/nm.2344. Epub 2011 Apr 3.

PMID:
21460848
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Prediction of epigenetically regulated genes in breast cancer cell lines.

Loss LA, Sadanandam A, Durinck S, Nautiyal S, Flaucher D, Carlton VE, Moorhead M, Lu Y, Gray JW, Faham M, Spellman P, Parvin B.

BMC Bioinformatics. 2010 Jun 4;11:305. doi: 10.1186/1471-2105-11-305.

PMID:
20525369
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.

Hu Z, Huang G, Sadanandam A, Gu S, Lenburg ME, Pai M, Bayani N, Blakely EA, Gray JW, Mao JH.

Breast Cancer Res. 2010;12(2):R18. doi: 10.1186/bcr2487. Epub 2010 Mar 8.

PMID:
20211017
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis.

Sadanandam A, Varney ML, Singh S, Ashour AE, Moniaux N, Deb S, Lele SM, Batra SK, Singh RK.

Int J Cancer. 2010 Sep 1;127(6):1373-83. doi: 10.1002/ijc.25166. Erratum in: Int J Cancer. 2012 Jun 15;130(12):E2.

PMID:
20073063
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047.

Kuo WL, Das D, Ziyad S, Bhattacharya S, Gibb WJ, Heiser LM, Sadanandam A, Fontenay GV, Hu Z, Wang NJ, Bayani N, Feiler HS, Neve RM, Wyrobek AJ, Spellman PT, Marton LJ, Gray JW.

BMC Med. 2009 Dec 14;7:77. doi: 10.1186/1741-7015-7-77.

PMID:
20003408
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis.

Sadanandam A, Rosenbaugh EG, Singh S, Varney M, Singh RK.

Microvasc Res. 2010 Jan;79(1):1-9. doi: 10.1016/j.mvr.2009.10.005. Epub 2009 Oct 19.

PMID:
19850054
[PubMed - indexed for MEDLINE]
17.

Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis.

Nannuru KC, Futakuchi M, Sadanandam A, Wilson TJ, Varney ML, Myers KJ, Li X, Marcusson EG, Singh RK.

Clin Exp Metastasis. 2009;26(7):797-808. doi: 10.1007/s10585-009-9279-2. Epub 2009 Jul 10.

PMID:
19590968
[PubMed - indexed for MEDLINE]
18.

Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion.

Singh S, Sadanandam A, Varney ML, Nannuru KC, Singh RK.

Int J Cancer. 2010 Jan 15;126(2):328-36. doi: 10.1002/ijc.24714.

PMID:
19585580
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion.

Singh S, Nannuru KC, Sadanandam A, Varney ML, Singh RK.

Br J Cancer. 2009 May 19;100(10):1638-46. doi: 10.1038/sj.bjc.6605055. Epub 2009 Apr 28.

PMID:
19401689
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Identification of semaphorin 5A interacting protein by applying apriori knowledge and peptide complementarity related to protein evolution and structure.

Sadanandam A, Varney ML, Singh RK.

Genomics Proteomics Bioinformatics. 2008 Dec;6(3-4):163-74. doi: 10.1016/S1672-0229(09)60004-8.

PMID:
19329067
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk